Parkin substrate and assay

Compositions and methods for modulating PGC-1α to treat huntington's disease

METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES USING NMDA RECEPTOR GLYCINE SITE ANTAGONISTS

Method for Diagnosing Neuro-Degenerative Disease

AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASES AND CONDITIONS

Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421

Assays for modulators of parkin activity using S5a as a parkin substrate

Compounds, compositions and methods for medical imaging of Parkinson's disease

Assays for diagnosis and therapeutics employing similarities and differences in blood serum concentrations of 3 forms of complement C3c and related protein biomarkers between amyotrophic lateral sclerosis and Parkinson's disease

Neuregulin-1 transgenic mouse and methods of use

Novel Use of Prrp and Receptor Thereof

Compositions and Methods For Modulating Dopamine Nerutransmission

DIAGNOSTIC MARKER FOR NEURODEGENERATIVE DISEASES

Lrp4/Corin Dopaminergic Neuron Progenitor Cell Markers

Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain

I kappa B kinase complex as a target for the treatment of Huntington's disease

Methods of identifying agents for treatment of schizophrenia and related disorders

METHODS OF IDENTIFYING AGENTS FOR TREATING NEUROLOGICAL DISORDERS

COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING TOXIC SUBSTANCES IN DISEASE STATES

Biomarkers for amyotrophic lateral sclerosis and methods using the same

Method for identifying MLK inhibitors for treatment of neurological conditions

Diagnostic Test For Parkinson's Disease

Specific marker Lmx1a on dopaminergic neurons

Neuroprotection with Beta-Lactam Compounds

P62 as a diagnostic tool for alzheimer's disease

TREATING TRINUCLEOTIDE REPEAT CONDITIONS

Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein

Reducing polyglutamine-based aggregation

Method of diagnosing myasthenia gravis and kits therefor

Neuroprotective activity of activated protein c independent of its anticoagulant activity

Methods for testing for the development of Huntington's disease

antibodies binding to a C-terminal fragment of apoliopoprotein E

Biomarkers for neurodegenerative disorders

Antagonist antibodies against GDF-8

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Melanocytes in therapy of neurodegenerative diseases

Oxidative stress measurement device and related methods

Method and composition to individualize Levodopa/Carbidopa therapy using a breath test

Methods for treating parkinsons disease and parkinsonism

Assay for neuromuscular diseases

Truncated fragments of alpha-synuclein in Lewy body disease

Receptor

Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands

Compositions and methods for detecting and treating motor neuron disorders

Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies

Methods of identification of biomarkers with mass spectrometry techniques

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Yeast screens for treatment of human disease

Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof

Method of detecting or diagnosing of a neurodegenerative disease or condition

Yeast screens for treatment of human disease

Methods for the treatment of alzheimers disease and compositions therefore

TRIM 5 related protein as a biomarker of neurodegenerative disease

2'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease

FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease

Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease

Methods for diagnosing episodic movement disorders and related conditions

Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide

I kappa B kinase complex as a target for the treatment of Huntington's disease

Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease

Nucleic acid sequences of human Rif1

Method for increasing synaptic growth or plasticity

Methods for diagnosing and treating Alzheimers disease and Parkinson's disease

Screening method and compounds for treating friedreich ataxia

Human schizophrenia gene

Biomarker for Parkinson's disease

Biomarkers for amyotrophic lateral sclerosis

Method for the selection of compounds useful for the treatment of huntington's disease

Amyloid beta-peptide and methods of use

Parkin protein as ubiquitin ligase

Method for screening for compounds that modulate P16 mediated regulation of NMDA receptors

Identification of genotype-selective agents for treating Huntington's disease

Identification of modulators of nitration and therapeutic uses thereof